NCT05260892

Brief Summary

The Narrow GM Implants were designed for oral functional rehabilitation using dental implants, allowing for treatment of patients with different bone qualities in the region of lateral incisors in the maxilla or the region of lateral and central incisors in the mandible. The objective of the study is to confirm the long-term safety and clinical performance of implants and abutments of the Narrow GM System in a daily dental practice setting, by means of a prospective collection of clinical data in an observational study using these devices. Devices will be used according to standard routine in daily practice, according to all indications as specified by the manufacturer in the instructions for use (IFU). 55 patients (needed to obtain a sample size of 55 implants) will be followed for 36 months and monitored for Adverse Events by the Investigators until the last protocol-related procedure of a patient is completed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2022

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

3.2 years

First QC Date

February 9, 2022

Last Update Submit

November 8, 2023

Conditions

Keywords

dental implantsoral rehabilitationextra narrow implants

Outcome Measures

Primary Outcomes (1)

  • Peri-implant bone level change

    Amount of peri-implant bone level change

    up to 36 months

Secondary Outcomes (7)

  • Periimplant bone level

    up to 36 months

  • Implant Survival

    up to 36 months

  • Implant success

    up to 36 months

  • Prosthetic Survival

    up to 36 months

  • Prosthetic Success

    up to 36 months

  • +2 more secondary outcomes

Study Arms (1)

Narrow GM

Patients presenting at least onde edentulous site rehabilitated with Narrow GM implant

Device: Narrow GM implants

Interventions

Rehabilitation of superior lateral incisors or inferior central and lateral incisors with narrow implants supporting single unit or partial prostheses

Narrow GM

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients presenting 18 years of age or more, with at least one edentulous site in the region of lateral incisors in the maxilla and/or lateral and central incisors in the mandible, who are qualified for rehabilitation with narrow implants and single-unit fixed prostheses. Patients that give written informed consent to participate in this clinical study.

You may qualify if:

  • Patients with 18 years of age or more
  • At least one edentulous site in the region of lateral incisors in the maxilla and/or lateral and central incisors in the mandible
  • Presence of natural adjacent and opposing tooth,
  • Qualified for rehabilitation with narrow implants and single-unit fixed prostheses.

You may not qualify if:

  • Signs of allergy or hypersensitivity to titanium
  • Periodontal disease
  • heavy smoking/alcohol drinking habits
  • bruxism
  • high use of bisphosphonate drugs or proton pump inhibitors (PPIs)
  • radiation therapy
  • diabetes
  • autoimmune diseases
  • uncontrolled systemic complications or diseases
  • incomplete jawbone growth
  • bleeding disorders
  • HIV
  • osteoporosis
  • pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Escola de Aperfeiçoamento Profissional dos Cirurgiões Dentistas de Goiás, EAPGOIAS.

Goiânia, Goiás, 74070-070, Brazil

RECRUITING

Universidade Federal de Uberlândia, Faculdade de Odontologia, Área de Oclusão Prótese Fixa e Materiais Odontológicos.

Uberlândia, Minas Gerais, 38408-100, Brazil

RECRUITING

Study Officials

  • Waleska C Furquim, PhD

    Neodent

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2022

First Posted

March 2, 2022

Study Start

October 1, 2022

Primary Completion

December 15, 2025

Study Completion

December 15, 2025

Last Updated

November 9, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations